Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | UCHL1 | P09936 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KLK7 | P49862 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67044 | 0.95 | HSD17B10 (0.69) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL27877016 | 0.95 | HSD17B10 (0.69) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL6219872 | 0.95 | HSD17B10 (0.69) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL67045 | 0.95 | HSD17B10 (0.69) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL85536 | 0.95 | HSD17B10 (0.69) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL20492528 | 0.94 | HSD17B10 (0.68) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| Ammonia Solution, Strong SCHEMBL28264574 | 0.94 | HSD17B10 (0.68) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| Hydrazine SCHEMBL28122430 | 0.92 | HSD17B10 (0.66) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL77858 | 0.90 | HSD17B10 (0.63) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 | |
| SCHEMBL65491 | 0.90 | HSD17B10 (0.63) | HSD17B10SMN1; SMN2RAB9ALMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016178250-A1 | PROCESS FOR THE PREPARATION OF DACLATASVIR | MYLAN LABORATORIES LIMITED (IN) | 2016-11-10 | — | — | WO | disclosed |
| EP-2499132-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011060000-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |